Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche ...

US biotech Genentech and its parent, Swiss pharma giant Roche (ROG: SIX), have announced plans to invest more than $700 ...

About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct ...

Roche’s Herceptin and Perjeta duo is already part of a well-established standard of care in early-stage HER2-positive breast ...

Roche and Genentech to spend $700 million building new manufacturing facility May 12, 2025 by Mai Tao Genentech , a ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

Roche's $1.25B investment in U.S. facilities boosts drug manufacturing and diabetes tech, creating thousands of jobs.

The 700,000 square-foot facility is expected to create 400 high-wage manufacturing jobs once operational.

The project could eventually add more than 400 manufacturing jobs and over 1,500 construction jobs during site development.